396 related articles for article (PubMed ID: 23506430)
1. Higher levels of small dense low-density lipoprotein (LDL) are associated with cardiac autonomic neuropathy in patients with type 2 diabetes.
Jang EH; Park YM; Hur J; Kim MK; Ko SH; Baek KH; Song KH; Lee KW; Kwon HS
Diabet Med; 2013 Jun; 30(6):694-701. PubMed ID: 23506430
[TBL] [Abstract][Full Text] [Related]
2. High and low vitamin D level is associated with cardiovascular autonomic neuropathy in people with Type 1 and Type 2 diabetes.
Hansen CS; Fleischer J; Vistisen D; Ridderstråle M; Jensen JS; Jørgensen ME
Diabet Med; 2017 Mar; 34(3):364-371. PubMed ID: 27696502
[TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
[TBL] [Abstract][Full Text] [Related]
4. Vitamin B12 deficiency is associated with cardiovascular autonomic neuropathy in patients with type 2 diabetes.
Hansen CS; Jensen JS; Ridderstråle M; Vistisen D; Jørgensen ME; Fleischer J
J Diabetes Complications; 2017 Jan; 31(1):202-208. PubMed ID: 27638143
[TBL] [Abstract][Full Text] [Related]
5. Significance of small dense low-density lipoproteins as coronary risk factor in diabetic and non-diabetic Korean populations.
Yoon Y; Song J; Park HD; Park KU; Kim JQ
Clin Chem Lab Med; 2005; 43(4):431-7. PubMed ID: 15899660
[TBL] [Abstract][Full Text] [Related]
6. Cholesteryl ester transfer protein in metabolic syndrome.
Sandhofer A; Kaser S; Ritsch A; Laimer M; Engl J; Paulweber B; Patsch JR; Ebenbichler CF
Obesity (Silver Spring); 2006 May; 14(5):812-8. PubMed ID: 16855190
[TBL] [Abstract][Full Text] [Related]
7. Risk of cardiac autonomic neuropathy in latent autoimmune diabetes in adults is similar to type 1 diabetes and lower compared to type 2 diabetes: A cross-sectional study.
Maddaloni E; Moretti C; Del Toro R; Sterpetti S; Ievolella MV; Arnesano G; Strollo R; Briganti SI; D'Onofrio L; Pozzilli P; Buzzetti R
Diabet Med; 2021 Feb; 38(2):e14455. PubMed ID: 33170958
[TBL] [Abstract][Full Text] [Related]
8. [Role of small dense low-density lipoprotein in coronary artery disease patients with normal plasma cholesterol levels].
Koba S; Hirano T; Sakaue T; Sakai K; Kondo T; Yorozuya M; Suzuki H; Murakami M; Katagiri T
J Cardiol; 2000 Dec; 36(6):371-8. PubMed ID: 11190580
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction.
Stampfer MJ; Krauss RM; Ma J; Blanche PJ; Holl LG; Sacks FM; Hennekens CH
JAMA; 1996 Sep; 276(11):882-8. PubMed ID: 8782637
[TBL] [Abstract][Full Text] [Related]
10. Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome.
Kim JJ; Chae SJ; Choi YM; Hwang KR; Song SH; Yoon SH; Kim SM; Ku SY; Kim SH; Kim JG; Moon SY
Hum Reprod; 2013 May; 28(5):1354-60. PubMed ID: 23477907
[TBL] [Abstract][Full Text] [Related]
11. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
Hayashi T; Hirano T; Yamamoto T; Ito Y; Adachi M
Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958
[TBL] [Abstract][Full Text] [Related]
12. Physiological serum bilirubin concentrations are inversely associated with the prevalence of cardiovascular autonomic neuropathy in patients with Type 2 diabetes.
Chung JO; Cho DH; Chung DJ; Chung MY
Diabet Med; 2014 Feb; 31(2):185-91. PubMed ID: 24147832
[TBL] [Abstract][Full Text] [Related]
13. In vivo corneal confocal microscopy as a novel non-invasive tool to investigate cardiac autonomic neuropathy in Type 1 diabetes.
Maddaloni E; Sabatino F; Del Toro R; Crugliano S; Grande S; Lauria Pantano A; Maurizi AR; Palermo A; Bonini S; Pozzilli P; Manfrini S
Diabet Med; 2015 Feb; 32(2):262-6. PubMed ID: 25251450
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl.
Malave H; Castro M; Burkle J; Voros S; Dayspring T; Honigberg R; Pourfarzib R
Am J Cardiol; 2012 Sep; 110(5):662-5. PubMed ID: 22621796
[TBL] [Abstract][Full Text] [Related]
15. Effect of intensive lipid-lowering strategy on low-density lipoprotein particle size in patients with type 2 diabetes mellitus.
Niemeijer-Kanters SD; Dallinga-Thie GM; de Ruijter-Heijstek FC; Algra A; Erkelens DW; Banga JD; Jansen H
Atherosclerosis; 2001 May; 156(1):209-16. PubMed ID: 11369016
[TBL] [Abstract][Full Text] [Related]
16. Effect of type 2 diabetes on various electrophoretic characteristics of low-density lipoprotein particles in women.
Blackburn P; Lemieux I; Lamarche B; Bergeron J; Perron P; Tremblay G; Gaudet D; Després JP
Diabetologia; 2004 Dec; 47(12):2114-7. PubMed ID: 15602652
[TBL] [Abstract][Full Text] [Related]
17. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
Tani S; Matsumoto M; Nagao K; Hirayama A
J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623
[TBL] [Abstract][Full Text] [Related]
18. Anemia, bilirubin, and cardiovascular autonomic neuropathy in patients with type 2 diabetes.
Chung JO; Park SY; Cho DH; Chung DJ; Chung MY
Medicine (Baltimore); 2017 Apr; 96(15):e6586. PubMed ID: 28403090
[TBL] [Abstract][Full Text] [Related]
19. Doxazosin reduces prevalence of small dense low density lipoprotein and remnant-like particle cholesterol levels in nondiabetic and diabetic hypertensive patients.
Hirano T; Yoshino G; Kashiwazaki K; Adachi M
Am J Hypertens; 2001 Sep; 14(9 Pt 1):908-13. PubMed ID: 11587157
[TBL] [Abstract][Full Text] [Related]
20. Association between cardiac autonomic neuropathy and hypertension and its potential influence on diabetic complications.
Ayad F; Belhadj M; Pariés J; Attali JR; Valensi P
Diabet Med; 2010 Jul; 27(7):804-11. PubMed ID: 20636962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
